ABSTRACT
Background Exposure to ambient air pollution is associated with a range of diseases. Biomarkers derived from DNA methylation (DNAm) indicate a potential pathway to human health differences, connecting disease pathogenesis and biological ageing. However, little is known about sensitive periods during the life course where air pollution might have a stronger impact on DNAm, or whether effects accumulate over time.
Objectives We examined associations between air pollution exposure across the life course and DNAm-based biomarkers of ageing.
Methods Data were derived from the Lothian Birth Cohort 1936. Participants’ residential history was linked to annual levels of PM2.5, SO2, NO2, and O3 around 1935, 1950, 1970, 1980, 1990, and 2001; pollutant concentrations were estimated using the EMEP4UK atmospheric chemistry transport model. Blood samples were obtained between ages of 70 and 80 years, and Horvath DNAmAge, Hannum DNAmAge, DNAmPhenoAge, DNAmGrimAge, and DNAm telomere length (DNAmTL) were computed. We applied the structured life-course modelling approach: least angle regression identified best-fit life-course models for a composite measure of air pollution (air quality index [AQI]), and mixed-effects regression estimated selected models for AQI and single pollutants.
Results We included 525 individuals with 1782 observations. In the total sample, increased air pollution around 1970 was associated with higher epigenetic age (AQI: b=0.622 year, 95%CI: 0.151, 1.094) measured with Horvath DNAmAge in late adulthood. We found shorter DNAmTL among males with higher air pollution around 1980 (AQI: b=-0.035 kilobase, 95%CI: -0.057, -0.014) and among females with higher exposure around 1935 (AQI: b=-0.036 kilobase, 95%CI: -0.059, -0.013). Findings passed false discovery rate correction for DNAmTL, and were more consistent for the pollutants PM2.5, SO2 and NO2.
Discussion We tested the life-course relationship between air pollution and DNAm-based biomarkers. Air pollution in utero and in young-to-mid adulthood is linked to accelerated epigenetic ageing and telomere-associated ageing in later life.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Economic and Social Research Council, UK (grant award ES/T003669/1). The LBC1936 study is supported by Age UK (Disconnected Mind project, which supported SEH), the US National Institutes of Health (R01AG054628, which supported SRC and IJD), and the University of Edinburgh). SRC was also supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (221890/Z/20/Z). The atmospheric chemistry transport modelling work was underpinned by the Natural Environment Research Council award number NE/R016429/1 as part of the UK-SCAPE programme delivering National Capability and a grant under the Improving Health with Environmental Data call from the Natural Environment Research Council, the Chief Scientist Office, and the Medical Research Council (NE/P010849/1).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The LBC1936 study was conducted according to the Declaration of Helsinki guidelines with ethical permission obtained from the Multi-Centre Research Ethics Committee for Scotland (MREC/01/0/56), Lothian Research Ethics Committee (wave 1, LREC/2003/2/29), and the Scotland A Research Ethics Committee (waves 2-4, 07/MRE00/58). Written consent was obtained from all participants.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflicts of Interest: No competing interest declared.
Data Availability
Data-availability statement: The LBCs study data have been the subject of many internal (within the University of Edinburgh) and external collaborations, which are encouraged. Those who have interests in outcomes other than cognitive domains are particularly encouraged to collaborate. Both LBC studies have clear data dictionaries which help researchers to discern whether the variables they wish to use are present; these provide a simple short title for each variable, alongside a longer, common-sense description/provenance of each variable. This information is available on the study website (https://www.ed.ac.uk/lothian-birth-cohorts) alongside comprehensive data grids listing all variables collected throughout both LBC studies and the wave at which they were introduced, an LBC Data Request Form and example Data Transfer Agreement. Initially, the Data Request Form is e-mailed to the Lothian Birth Cohorts Director Dr Simon R. Cox for approval (via a panel comprising study co-investigators). Instances where approved projects require transfer of data or materials outside the University of Edinburgh require a formal Data Transfer Agreement or Material Transfer Agreement to be established with the host institution. The process is facilitated by a full-time LBC database manager, there is no charge.